Publications by authors named "Philippe Weber"

Claim this Profile
C
Clinical isolates of Escherichia coli solely resistant to mecillinam: prevalence and epidemiology.
Aurore Bousquet, Sarah Bugier, Sébastien Larréché, Christine Bigaillon, Philippe Weber

Int J Antimicrob Agents· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Organochlorines in Danish women: predictors of adipose tissue concentrations.
Elvira Vaclavik, Anne Tjonneland, Connie Stripp, Kim Overvad, Jean Philippe Weber

Environ Res· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction of antibiotic use in the community reduces the rate of colonization with penicillin G-nonsusceptible Streptococcus pneumoniae.
Didier Guillemot, Emmanuelle Varon, Claire Bernède, Philippe Weber, Laurence Henriet

Clin Infect Dis· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adipose organochlorine concentrations and risk of breast cancer among postmenopausal Danish women.
Ole Raaschou-Nielsen, Marian Pavuk, Alain Leblanc, Pierre Dumas, Jean Philippe Weber

Cancer Epidemiol Biomarkers Prev· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amoxicillin-clavulanate therapy increases childhood nasal colonization by methicillin-susceptible Staphylococcus aureus strains producing high levels of penicillinase.
Didier Guillemot, Stephane Bonacorsi, John S Blanchard, Philippe Weber, Sylvie Simon

Antimicrob Agents Chemother· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New highly selective inhibitors of class II fructose-1,6-bisphosphate aldolases.
Matthieu Fonvielle, Philippe Weber, Kasia Dabkowska, Michel Therisod

Bioorg Med Chem Lett· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five day clarithromycin modified release versus 10 day penicillin V for group A streptococcal pharyngitis: a multi-centre, open-label, randomized study.
Henri Portier, Jamila Filipecki, Philippe Weber, Gerard Goldfarb, Denis Lethuaire

J Antimicrob Chemother· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of 5-day cefpodoxime proxetil for recurrent pharyngitis in adults. A comparative study with 10-day penicillin V or amoxycillin---clavulanate.
Henri Portier, Pierre Gehanno, Philippe Weber, Henri Dabernat, Françoise Ichou

Clin Microbiol Infect· August 1997

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis